Overview
Rare diabetes mellitus type 1 (also referred to as rare forms of type 1 diabetes or atypical type 1 diabetes) encompasses uncommon subtypes and presentations of type 1 diabetes mellitus that do not fit the classical autoimmune or idiopathic categories typically seen in the general population. Type 1 diabetes mellitus is characterized by the destruction or dysfunction of insulin-producing beta cells in the pancreas, leading to absolute insulin deficiency. In rare forms, the underlying mechanisms may involve unusual genetic, immunological, or syndromic causes that distinguish them from the more common autoimmune type 1 diabetes (type 1A) and idiopathic type 1 diabetes (type 1B). The disease primarily affects the endocrine system, specifically the pancreatic islets of Langerhans. Key clinical features include hyperglycemia, polyuria (excessive urination), polydipsia (excessive thirst), unexplained weight loss, fatigue, and a propensity for diabetic ketoacidosis. Because insulin production is severely impaired or absent, patients are dependent on exogenous insulin therapy for survival. Long-term complications can affect multiple organ systems, including the cardiovascular system, kidneys (diabetic nephropathy), eyes (diabetic retinopathy), and peripheral nervous system (diabetic neuropathy). Treatment centers on lifelong insulin replacement therapy, delivered via multiple daily injections or continuous subcutaneous insulin infusion (insulin pump therapy). Careful blood glucose monitoring, dietary management, and regular screening for microvascular and macrovascular complications are essential components of care. In some rare subtypes, additional genetic or syndromic features may require multidisciplinary management. Advances in continuous glucose monitoring and closed-loop insulin delivery systems have improved quality of life for many patients. Pancreatic islet transplantation remains an option in select refractory cases.
Also known as:
Variable
Can be inherited in different ways depending on the underlying gene
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
1 eventUniversity of Baghdad — NA
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Rare diabetes mellitus type 1.
1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Rare diabetes mellitus type 1.
Community
No community posts yet. Be the first to share your experience with Rare diabetes mellitus type 1.
Start the conversation →Latest news about Rare diabetes mellitus type 1
Disease timeline:
New trial: Pharmacist Led Educational Intervention on QOL, Medication Adherence & Satisfaction on Patients With
Phase NA trial recruiting. Educational intervension
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Rare diabetes mellitus type 1
What is Rare diabetes mellitus type 1?
Rare diabetes mellitus type 1 (also referred to as rare forms of type 1 diabetes or atypical type 1 diabetes) encompasses uncommon subtypes and presentations of type 1 diabetes mellitus that do not fit the classical autoimmune or idiopathic categories typically seen in the general population. Type 1 diabetes mellitus is characterized by the destruction or dysfunction of insulin-producing beta cells in the pancreas, leading to absolute insulin deficiency. In rare forms, the underlying mechanisms may involve unusual genetic, immunological, or syndromic causes that distinguish them from the more
Are there clinical trials for Rare diabetes mellitus type 1?
Yes — 1 recruiting clinical trial is currently listed for Rare diabetes mellitus type 1 on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Rare diabetes mellitus type 1?
2 specialists and care centers treating Rare diabetes mellitus type 1 are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.